warning signs. developing brain scans and other biomarkers that detect early stages of Alzheimer's disease is a priority for researchers.
US National Institute on Aging, education and Alzheimer Reference Center
An international panel of experts issued recommendations today for future research on Alzheimer's disease. The recommendations will help guide the research component of the new national plan for Alzheimer announced Tuesday by Health and Human Services Secretary Kathleen Sebelius. The plan sets the ambitious goal of developing effective prevention and treatment strategies for Alzheimer's disease in 2025.
The new research strategy has been developed by experts who gathered at a summit of two days at the US National Institutes of Health (NIH) in Bethesda, Maryland, earlier this week. The group recognizes a number of challenges on the ground, including the need to develop better experimental models and initiate clinical trials in early stages of the disease. Their recommendations include conduct more interdisciplinary research on the biological mechanisms of Alzheimer's disease and drug targets, allowing faster and extensive sharing of data and biological samples, and to encourage more public-private partnerships (the along the lines of the neuroimaging Initiative for Alzheimer's disease, biomarker successfully jointly funded development effort by the pharmaceutical industry and NIH). The group also calls for more research on non-drug interventions, such as lifestyle changes, that might prevent or slow the disease.
A financial stimulus for Alzheimer's research seems to be in the works: draft budget of President Barack Obama in 2013 includes $ 80 million in new funding. Congress has yet to weigh in on the plan.
0 Komentar